Skip to main navigation Skip to search Skip to main content

Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study

  • Martin H. Ellis*
  • , Sari Greenberg Dotan
  • , Ariel Hammerman
  • , Erez Battat
  • , Estela Derazne
  • , Orly Avnery
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish
Pages (from-to)140-142
Number of pages3
JournalThrombosis Research
Volume169
DOIs
StatePublished - Sep 2018

Keywords

  • Atrial fibrillation
  • NOAC dose
  • Population study

Cite this